The GH/IGF-1 system in critical illness

被引：66
|
作者：
Elijah, Itoro E.
Branski, Ludwik K.
Finnerty, Celeste C.
Herndon, David N. [1 ]
机构：
[1] Univ Texas Med Branch, Dept Surg, Galveston, TX 77550 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2011年 / 25卷 / 05期
基金：
美国国家卫生研究院;
关键词：
trauma; burns; hypermetabolism; protein wasting; IGFBP-3; hepatic acute care response; gut atrophy; nutrition; mortality; anabolic therapy; GROWTH-FACTOR-I; HORMONE TREATMENT; GENE-TRANSFER; BACTERIAL TRANSLOCATION; CATIONIC LIPOSOMES; MESSENGER-RNA; EXPRESSION; THERAPY; PROTEINS; SERUM;
D O I：
10.1016/j.beem.2011.06.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) axis plays a pivotal role in critical illness, with a derangement leading to profound changes in metabolism. Protein wasting with skeletal muscle loss, delayed wound healing, and impaired recovery of organ systems are some of the most feared consequences. The use of human recombinant Growth Hormone (rhGH) and Insulin-like Growth Factor-1 (IGF-1) - alone and in combination - has been studied extensively in preclinical and clinical trials. This article reviews the current knowlegde and clinical practice of the use of rhGh and IGF-1 in critically ill patients, with a special focus on the trauma and burns patient population. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：759 / 767
页数：9
相关论文
共 50 条
  • [1] Treatment with GH and IGF-1 in critical illness
    Chung, TT
    Hinds, CJ
    CRITICAL CARE CLINICS, 2006, 22 (01) : 29 - +
  • [2] RESISTANCE OF HUMAN OA CHONDROCYTES TO GH AND IGF-1 ACTION - GH RECEPTOR AND IGF-1 BIOAVAILABILITY DEFECTS
    MARTELPELLETIER, J
    DORE, S
    TARDIF, G
    DIBATTISTA, JA
    ABRIBAT, T
    PELLETIER, JP
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S191 - S191
  • [3] Nutrition, GH/IGF-1 signaling, and cancer
    Fanti, Maura
    Longo, Valter D.
    ENDOCRINE-RELATED CANCER, 2024, 31 (11)
  • [4] The GH/IGF-1 Axis and Heart Failure
    Castellano, Graziella
    Affuso, Flora
    Di Conza, Pasquale
    Fazio, Serafino
    CURRENT CARDIOLOGY REVIEWS, 2009, 5 (03) : 203 - 215
  • [5] The GH/IGF-1 axis in ageing and longevity
    Junnila, Riia K.
    List, Edward O.
    Berryman, Darlene E.
    Murrey, John W.
    Kopchick, John J.
    NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (06) : 366 - 376
  • [6] The GH/IGF-1 axis in ageing and longevity
    Riia K. Junnila
    Edward O. List
    Darlene E. Berryman
    John W. Murrey
    John J. Kopchick
    Nature Reviews Endocrinology, 2013, 9 : 366 - 376
  • [7] Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis
    Locatelli, Vittorio
    Bianchi, Vittorio E.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [8] DIFFERENTIAL ACTIONS OF GH VS. IGF-1
    Kopchick, J. J.
    GERONTOLOGIST, 2013, 53 : 505 - 505
  • [9] IGF-1 and GH alterations in lambs with intestinal inflammation
    Temizel, Ethem Mutlu
    Karakus, Adil Omer
    Kavukcu, Fatih
    Kucuksen, Duygu Udum
    Ercan, Ilker
    TURKISH JOURNAL OF VETERINARY & ANIMAL SCIENCES, 2021, 45 (02): : 354 - 362
  • [10] GH/IGF-1 axis in patients with subclinical hypothyroidism
    Akin, Fulya
    Bastemir, Mehmet
    Yaylali, Guzin Fidan
    Alkis, Esma
    Kaptanoglu, Bunyamin
    CLINICAL ENDOCRINOLOGY, 2008, 68 (06) : 1009 - 1010
12345